Drugs / P2-VP8 Subunit Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02109484 | Mar 2014 → Nov 2015 | — | PATH | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P2-VP8 Subunit Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02109484 ↗ |
| Known as | P2-VP8-P[8] | “Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.” PMID 28483414 ↗ May 2017 |
| Modality | Vaccine | “parenteral rotavirus vaccine” NCT02109484 ↗ |